Evidence map›Paper›PMID 41011619›Full record

ArticleMolecules (Basel, Switzerland)2025

Combination of Plasma Pharmacochemistry, RNA-Seq, and Molecular Docking Strategies to Reveal the Mechanism of the Alkaloid Fraction of

Yuan Cai, Rong Huang, Tianfeng Lin, Leyi Yang, Chang Zhou, Yumiao Li, Bin Liu, Shifen Dong, Yanyan Jiang

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yuan CaiSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China.
Rong HuangSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China.
Tianfeng LinSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China.
Leyi YangSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China.
Chang ZhouSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China.
Yumiao LiSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China.
Bin LiuSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China.
Shifen DongSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China.ORCID 0000-0002-2194-8541
Yanyan JiangSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China.

Funding

Natural Science Foundation of Beijing, China 7192117
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AlkaloidsHyperlipidemiasHypolipidemic AgentsMolecular Docking SimulationNelumboPlant ExtractsAnimalsMaleMiceRNA-SeqAlkaloidsHypolipidemic AgentsPlant Extractsalkaloid fraction of Nelumbinis foliumhyperlipidemiamolecular docking technologyplasma pharmacochemistrytranscriptome-sequencing technology

Identifiers

PMID41011619
PMCPMC12472672

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.